Drug Shortage Report for PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%
Report ID | 113825 |
Drug Identification Number | 02238400 |
Brand name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% |
Common or Proper name | Phenylephrine Hydrochloride Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 x 1mL vial / fiole |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-01 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-05-22 |
Shortage status | Resolved |
Updated date | 2020-05-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-05-26 | French | Compare |
v4 | 2020-05-26 | English | Compare |
v3 | 2020-05-02 | English | Compare |
v2 | 2020-05-01 | French | Compare |
v1 | 2020-05-01 | English | Compare |
Showing 1 to 5 of 5